{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:58:49Z","timestamp":1786978729658,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":45,"publisher":"Springer US","isbn-type":[{"value":"9781071647417","type":"print"},{"value":"9781071647424","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4742-4_16","type":"book-chapter","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:28:59Z","timestamp":1756398539000},"page":"341-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lipid Nanoparticles for the Delivery of mRNA"],"prefix":"10.1007","author":[{"given":"Sandra","family":"Paroor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwin T","family":"Shaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Bino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navya G","family":"Praveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Unnipurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvathy","family":"Anil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosmy","family":"Geo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Easa","family":"Nagamalleswari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa Reddy","family":"Bonam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Kurapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2019.04.017","volume":"454","author":"Q Luo","year":"2019","unstructured":"Luo Q, Zhang L, Luo C, Jiang M (2019) Emerging strategies in cancer therapy combining chemotherapy with immunotherapy. Cancer Lett 454:191","journal-title":"Cancer Lett"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"XC Hou","year":"2021","unstructured":"Hou XC, Zaks T, Langer R, Dong YZ (2021) Lipid nanoparticles for mRNA delivery. Nat Rev Mater 6:1078","journal-title":"Nat Rev Mater"},{"key":"16_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168297","volume":"435","author":"S Pagliari","year":"2023","unstructured":"Pagliari S, Dema B, Sanchez-Martinez A, Zurbia-Flores GM, Rollier CS (2023) DNA vaccines: history, molecular mechanisms and future perspectives. J Mol Biol 435:168297","journal-title":"J Mol Biol"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/vaccines11030658","volume":"11","author":"K Swetha","year":"2023","unstructured":"Swetha K, Kotla NG, Tunki L, Jayaraj A, Bhargava SK, Hu HT, Bonam SR, Kurapati R (2023) Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines. Vaccines 11:658","journal-title":"Vaccines"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou QQ (2021) Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15:16982","journal-title":"ACS Nano"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/vaccines9040359","volume":"9","author":"TTH Thi","year":"2021","unstructured":"Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP (2021) Lipid-based nanoparticles in the clinic and clinical trials: from cancer nanomedicine to COVID-19 vaccines. Vaccines 9:359","journal-title":"Vaccines"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","volume":"144","author":"YZ Dong","year":"2019","unstructured":"Dong YZ, Siegwart DJ, Anderson DG (2019) Strategies, design, and chemistry in siRNA delivery systems. Adv Drug Deliv Rev 144:133","journal-title":"Adv Drug Deliv Rev"},{"key":"16_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","volume":"160","author":"Y Barenholz","year":"2012","unstructured":"Barenholz Y (2012) Doxil\u00ae \u2013 the first FDA-approved nano-drug: lessons learned. J Control Release 160:117","journal-title":"J Control Release"},{"key":"16_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202303261","volume":"35","author":"Y Zong","year":"2023","unstructured":"Zong Y, Lin Y, Wei T, Cheng Q (2023) Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy. Adv Mater 35:e2303261","journal-title":"Adv Mater"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1586\/era.09.69","volume":"9","author":"PA Meyers","year":"2009","unstructured":"Meyers PA (2009) Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma. Expert Rev Anticancer Ther 9:1035","journal-title":"Expert Rev Anticancer Ther"},{"key":"16_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2022.102635","volume":"48","author":"L Almenara-Fuentes","year":"2023","unstructured":"Almenara-Fuentes L, Rodriguez-Fernandez S, Rosell-Mases E, Kachler K, You AX, Salvado M, Andreev D, Steffen U, Bang H, Bozec A, Schett G, Le Panse R, Verdaguer J, Dalmases M, Rodriguez-Vidal S, Barneda-Zahonero B, Vives-Pi M (2023) A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine 48:102635","journal-title":"Nanomedicine"},{"key":"16_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120734","volume":"305","author":"NAA Suhaimi","year":"2022","unstructured":"Suhaimi NAA, Ahmad S, Husna SMN, Sarmiento ME, Acosta A, Norazmi MN, Ibrahim J, Mohamud R, Kadir R (2022) Application of liposomes in the treatment of infectious diseases. Life Sci 305:120734","journal-title":"Life Sci"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary N, Weissman D, Whitehead KA (2021) mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov 20:817","journal-title":"Nat Rev Drug Discov"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/pharmaceutics13040520","volume":"13","author":"TQ Wang","year":"2021","unstructured":"Wang TQ, Suita Y, Miriyala S, Dean J, Tapinos N, Shen J (2021) Advances in lipid-based nanoparticles for cancer chemoimmunotherapy. Pharmaceutics 13:520","journal-title":"Pharmaceutics"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"G Sahay","year":"2022","unstructured":"Sahay G, Eygeris Y, Gupta M, Kim J (2022) Chemistry of lipid nanoparticles for RNA delivery. Acc Chem Res 55:2","journal-title":"Acc Chem Res"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1039\/c3tb21238f","volume":"1","author":"WW Gao","year":"2023","unstructured":"Gao WW, Hu CMJ, Fang RH, Zhang LF (2023) Liposome-like nanostructures for drug delivery. J Mater Chem B 1:6569","journal-title":"J Mater Chem B"},{"key":"16_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"CH Albertsen","year":"2022","unstructured":"Albertsen CH, Kulkarni JA, Witzigmann D, Lind M, Petersson K, Simonsen JB (2022) The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev 188:114416","journal-title":"Adv Drug Deliv Rev"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1021\/jacs.2c10670","volume":"145","author":"G Tilstra","year":"2023","unstructured":"Tilstra G, Couture-Senecal J, Lau YMA, Manning AM, Wong DSM, Janaeska WW, Wuraola TA, Pang JNC, Khan OF (2023) Iterative design of ionizable lipids for intramuscular mRNA delivery. J Am Chem Soc 145:2294","journal-title":"J Am Chem Soc"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","volume":"99","author":"XW Cheng","year":"2016","unstructured":"Cheng XW, Lee RJ, The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery (2016) Adv Drug Deliv Rev 99:129","journal-title":"Adv Drug Deliv Rev"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.xphs.2022.12.026","volume":"112","author":"M Kawaguchi","year":"2023","unstructured":"Kawaguchi M, Noda M, Ono A, Kamiya M, Matsumoto M, Tsurumaru M, Mizukami S, Mukai H, Kawakami S (2023) Effect of cholesterol content of lipid composition in mRNA-LNPs on the protein expression in the injected site and liver after local administration in mice. J Pharm Sci 112:1401","journal-title":"J Pharm Sci"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/pharmaceutics16020181","volume":"16","author":"J Anindita","year":"2024","unstructured":"Anindita J, Tanaka H, Yamakawa T, Sato Y, Matsumoto C, Ishizaki K, Oyama T, Suzuki S, Ueda K, Higashi K, Moribe K, Sasaki K, Ogura Y, Yonemochi E, Sakurai Y, Hatakeyama H, Akita H (2024) The effect of cholesterol content on the adjuvant activity of nucleic-acid-free lipid nanoparticles. Pharmaceutics 16:181","journal-title":"Pharmaceutics"},{"key":"16_CR22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel S, Ashwanikumar N, Robinson E, Xia Y, Mihai C, Griffith JP, Hou SG, Esposito AA, Ketova T, Welsher K, Joyal JL, Almarsson \u00d6, Sahay G (2020) Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat Commun 11:983","journal-title":"Nat Commun"},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2217\/nnm.11.19","volume":"6","author":"JV Jokerst","year":"2011","unstructured":"Jokerst JV, Lobovkina T, Zare RN, Gambhir SS (2011) Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6:715","journal-title":"Nanomedicine"},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/pharmaceutics15020597","volume":"15","author":"M Berger","year":"2023","unstructured":"Berger M, Degey M, Chain JL, Maquoi E, Evrard B, Lechanteur A, Piel G (2023) Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method. Pharmaceutics 15:597","journal-title":"Pharmaceutics"},{"key":"16_CR25","doi-asserted-by":"publisher","first-page":"1466337","DOI":"10.3389\/fphar.2024.1466337","volume":"15","author":"O Vasileva","year":"2024","unstructured":"Vasileva O, Zaborova O, Shmykov B, Ivanov R, Reshetnikov V (2024) Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics. Front Pharmacol 15:1466337","journal-title":"Front Pharmacol"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","volume":"34","author":"R Tenchov","year":"2023","unstructured":"Tenchov R, Sasso JM, Zhou QA (2023) PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective. Bioconjug Chem 34:941","journal-title":"Bioconjug Chem"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12951-024-02812-x","volume":"22","author":"WW Kong","year":"2024","unstructured":"Kong WW, Wei YN, Dong ZR, Liu WJ, Zhao JX, Huang Y, Yang JL, Wu W, He HS, Qi JP (2024) Role of size, surface charge, and PEGylated lipids of lipid nanoparticles (LNPs) on intramuscular delivery of mRNA. J Nanobiotechnol 22:553","journal-title":"J Nanobiotechnol"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"XX Han","year":"2021","unstructured":"Han XX, Zhang HW, Butowska K, Swingle KL, Alameh MG, Weissman D, Mitchell MJ (2021) An ionizable lipid toolbox for RNA delivery. Nat Commun 12:7233","journal-title":"Nat Commun"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"14397","DOI":"10.1002\/anie.201408221","volume":"53","author":"OF Khan","year":"2014","unstructured":"Khan OF, Zaia EW, Yin H, Bogorad RL, Pelet JM, Webber MJ, Zhuang I, Dahlman JE, Langer R, Anderson DG (2014) Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo. Angew Chem Int Ed 53:14397","journal-title":"Angew Chem Int Ed"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"2200071","DOI":"10.1002\/smsc.202200071","volume":"3","author":"K Hashiba","year":"2022","unstructured":"Hashiba K, Sato Y, Taguchi M, Sakamoto S, Otsu A, Maeda Y, Shishido T, Murakawa M, Okazaki A, Harashima H (2022) Branching ionizable lipids can enhance the stability, fusogenicity, and functional delivery of mRNA. Small Sci 3:2200071","journal-title":"Small Sci"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"3769","DOI":"10.1016\/j.xphs.2019.09.009","volume":"108","author":"E Damiani","year":"2019","unstructured":"Damiani E, Puglia C (2019) Nanocarriers and microcarriers for enhancing the UV protection of sunscreens: an overview. J Pharm Sci 108:3769","journal-title":"J Pharm Sci"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D (2018) mRNA vaccines \u2013 a new era in vaccinology. Nat Rev Drug Discov 17:261","journal-title":"Nat Rev Drug Discov"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","volume":"390","author":"M Alberer","year":"2017","unstructured":"Alberer M, Gnad-Vogt U, Hong HS, Mehr KT, Backert L, Finak G, Gottardo R, Bica MA, Garofano A, Koch SD, Fotin-Mleczek M, Hoerr I, Clemens R, von Sonnenburg F (2017) Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet 390:1511","journal-title":"Lancet"},{"key":"16_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett KJ, Benenato KE, Jacquinet E, Lee A, Woods A, Yuzhakov O, Himansu S, Deterling J, Geilich BM, Ketova T, Mihai C, Lynn A, McFadyen I, Moore MJ, Senn JJ, Stanton MG, Almarsson \u00d6, Ciaramella G, Brito LA (2019) Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol Ther Nucleic Acids 15:1","journal-title":"Mol Ther Nucleic Acids"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.omtn.2022.09.017","volume":"30","author":"Y Suzuki","year":"2022","unstructured":"Suzuki Y, Miyazaki T, Muto H, Kubara K, Mukai Y, Watari R, Sato S, Kondo K, Tsukumo SI, Yasutomo K, Ito M, Tsukahara K (2022) Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates. Molecular Ther Nucleic Acids 30:226","journal-title":"Molecular Ther Nucleic Acids"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","volume":"154","author":"S Shah","year":"2020","unstructured":"Shah S, Dhawan V, Holm R, Nagarsenker MS, Perrie Y (2020) Liposomes: advancements and innovation in the manufacturing process. Adv Drug Deliv Rev 154:102","journal-title":"Adv Drug Deliv Rev"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"7867","DOI":"10.1021\/acsanm.2c00886","volume":"5","author":"Y Matsuura-Sawada","year":"2022","unstructured":"Matsuura-Sawada Y, Maeki M, Nishioka T, Niwa A, Yamauchi J, Mizoguchi M, Wada K, Tokeshi M (2022) Microfluidic device-enabled mass production of lipid-based nanoparticles for applications in nanomedicine and cosmetics. ACS Appl Nano Mater 5:7867","journal-title":"ACS Appl Nano Mater"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1021\/acs.nanolett.6b03251","volume":"17","author":"DF Liu","year":"2017","unstructured":"Liu DF, Zhang HB, Cito S, Fan J, M\u00e4kil\u00e4 E, Salonen J, Hirvonen J, Sikanen TM, Weitz DA, Santos HA (2017) Core\/Shell nanocomposites produced by superfast sequential microfluidic nanoprecipitation. Nano Lett 17:606","journal-title":"Nano Lett"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.3390\/pharmaceutics14122682","volume":"14","author":"L Yang","year":"2022","unstructured":"Yang L, Gong LM, Wang P, Zhao XH, Zhao F, Zhang ZJ, Li YF, Huang W (2022) Recent advances in lipid nanoparticles for delivery of mRNA. Pharmaceutics 14:2682","journal-title":"Pharmaceutics"},{"key":"16_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117108","volume":"178","author":"S Chen","year":"2024","unstructured":"Chen S, Deng ZH, Ji D (2024) Advances in the development of lipid nanoparticles for ophthalmic therapeutics. Biomed Pharmacother 178:117108","journal-title":"Biomed Pharmacother"},{"key":"16_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1021\/acsnanoscienceau.2c00062","volume":"3","author":"X Xu","year":"2023","unstructured":"Xu X, Xia T (2023) Recent advances in site-specific lipid nanoparticles for mRNA delivery. ACS Nanosci Au 3:192","journal-title":"ACS Nanosci Au"},{"key":"16_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2024.08.030","volume":"375","author":"PS Wei","year":"2024","unstructured":"Wei PS, Thota N, John G, Chang E, Lee S, Wang YJ, Ma ZT, Tsai YH, Mei KC (2024) Enhancing RNA-lipid nanoparticle delivery: organ- and cell-specificity and barcoding strategies. J Control Release 375:366","journal-title":"J Control Release"},{"key":"16_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114990","volume":"200","author":"M Jeong","year":"2023","unstructured":"Jeong M, Lee Y, Park J, Jung H, Lee H (2023) Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications. Adv Drug Deliv Rev 200:114990","journal-title":"Adv Drug Deliv Rev"},{"key":"16_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.partic.2023.11.014","volume":"90","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Wu YQ, Cheng JB, Yang KY, Xia YL, Wu HG, Pan XY (2024) Applications of artificial intelligence to lipid nanoparticle delivery. Particuology 90:88","journal-title":"Particuology"},{"key":"16_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41541-020-0163-z","volume":"5","author":"AS Espeseth","year":"2020","unstructured":"Espeseth AS, Cejas PJ, Citron MP, Wang D, DiStefano DJ, Callahan C, Donnell GO, Galli JD, Swoyer R, Touch S, Wen Z, Antonello J, Zhang L, Flynn JA, Cox KS, Freed DC, Vora KA, Bahl K, Latham AH, Smith JS, Gindy ME, Ciaramella G, Hazuda D, Shaw CA, Bett AJ (2020) Modified mRNA\/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection. npj Vaccines 5:16","journal-title":"npj Vaccines"}],"container-title":["Methods in Molecular Biology","RNA Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4742-4_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:01:38Z","timestamp":1774767698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4742-4_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647417","9781071647424"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4742-4_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 August 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}